Dmitry Kirtbaya

机构：Ministry of Health of the Russian Federation

发表论文 4 篇 · 总被引 89 次 · h-index 3

代表论文

• Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma (2025 · New England Journal of Medicine · 被引 68)
• CHRONOS-4: phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma (2024 · Blood Advances · 被引 17)
• C-POST protocol update: A phase 3, randomized, double-blind study of adjuvant cemiplimab versus placebo post-surgery and radiation therapy (RT) in patients (pts) with high-risk cutaneous squamous cell carcinoma (CSCC). (2022 · Journal of Clinical Oncology · 被引 4)
• C-POST protocol update: A Phase 3, randomized, double-blind study of adjuvant cemiplimab versus placebo post surgery and radiation therapy in patients with high-risk cutaneous squamous cell carcinoma (2023 · SKIN The Journal of Cutaneous Medicine)